Skip to Content

TL 383 TL 383 (Terazosin Hydrochloride 1 mg)

Pill with imprint TL 383 TL 383 is Gray, Capsule-shape and has been identified as Terazosin Hydrochloride 1 mg. It is supplied by Cadista.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TL 383 TL 383

Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383

Terazosin Hydrochloride

Imprint:
TL 383 TL 383
Strength:
1 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cadista
Inactive Ingredients:
ferrosoferric oxide
gelatin
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
corn starch
silicon dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
67544-0581 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide